The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zovirax 200mg Dispersible Tablets

200 milligram(s) Dispersible tablet

Imbat LimitedPPA1151/028/002

Main Information

Trade NameZovirax 200mg Dispersible Tablets
Active SubstancesACICLOVIR
Strength200 milligram(s)
Dosage FormDispersible tablet
Licence HolderImbat Limited
Licence NumberPPA1151/028/002

Group Information

ATC CodeJ05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB01 aciclovir

Status

Authorised/WithdrawnAuthorised
Licence Issued20/12/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back